Non-Alcoholic Fatty Liver Disease, and the Underlying Altered Fatty Acid Metabolism, Reveals Brain Hypoperfusion and Contributes to the Cognitive Decline in APP/PS1 Mice
- Supplementary File 1:
PDF-Document (PDF, 472 KiB)
Pinçon, A.; De Montgolfier, O.; Akkoyunlu, N.; Daneault, C.; Pouliot, P.; Villeneuve, L.; Lesage, F.; Levy, B.I.; Thorin-Trescases, N.; Thorin, É.; Ruiz, M. Non-Alcoholic Fatty Liver Disease, and the Underlying Altered Fatty Acid Metabolism, Reveals Brain Hypoperfusion and Contributes to the Cognitive Decline in APP/PS1 Mice. Metabolites 2019, 9, 104. https://doi.org/10.3390/metabo9050104
Pinçon A, De Montgolfier O, Akkoyunlu N, Daneault C, Pouliot P, Villeneuve L, Lesage F, Levy BI, Thorin-Trescases N, Thorin É, Ruiz M. Non-Alcoholic Fatty Liver Disease, and the Underlying Altered Fatty Acid Metabolism, Reveals Brain Hypoperfusion and Contributes to the Cognitive Decline in APP/PS1 Mice. Metabolites. 2019; 9(5):104. https://doi.org/10.3390/metabo9050104
Chicago/Turabian StylePinçon, Anthony; De Montgolfier, Olivia; Akkoyunlu, Nilay; Daneault, Caroline; Pouliot, Philippe; Villeneuve, Louis; Lesage, Frédéric; Levy, Bernard I.; Thorin-Trescases, Nathalie; Thorin, Éric; Ruiz, Matthieu. 2019. "Non-Alcoholic Fatty Liver Disease, and the Underlying Altered Fatty Acid Metabolism, Reveals Brain Hypoperfusion and Contributes to the Cognitive Decline in APP/PS1 Mice" Metabolites 9, no. 5: 104. https://doi.org/10.3390/metabo9050104